165 related articles for article (PubMed ID: 19264680)
1. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.
Robach P; Recalcati S; Girelli D; Gelfi C; Aachmann-Andersen NJ; Thomsen JJ; Norgaard AM; Alberghini A; Campostrini N; Castagna A; Viganò A; Santambrogio P; Kempf T; Wollert KC; Moutereau S; Lundby C; Cairo G
Blood; 2009 Jun; 113(26):6707-15. PubMed ID: 19264680
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.
Sasaki Y; Noguchi-Sasaki M; Yasuno H; Yorozu K; Shimonaka Y
Int J Hematol; 2012 Dec; 96(6):692-700. PubMed ID: 23160767
[TBL] [Abstract][Full Text] [Related]
3. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle.
Robach P; Cairo G; Gelfi C; Bernuzzi F; Pilegaard H; Viganò A; Santambrogio P; Cerretelli P; Calbet JA; Moutereau S; Lundby C
Blood; 2007 Jun; 109(11):4724-31. PubMed ID: 17311997
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.
Vokurka M; Krijt J; Sulc K; Necas E
Physiol Res; 2006; 55(6):667-674. PubMed ID: 16497104
[TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
Robach P; Recalcati S; Girelli D; Campostrini N; Kempf T; Wollert KC; Corbella M; Santambrogio P; Perbellini L; Brasse-Lagnel C; Christensen B; Moutereau S; Lundby C; Cairo G
Eur J Haematol; 2013 Jul; 91(1):74-84. PubMed ID: 23582009
[TBL] [Abstract][Full Text] [Related]
6. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
Piperno A; Galimberti S; Mariani R; Pelucchi S; Ravasi G; Lombardi C; Bilo G; Revera M; Giuliano A; Faini A; Mainini V; Westerman M; Ganz T; Valsecchi MG; Mancia G; Parati G;
Blood; 2011 Mar; 117(10):2953-9. PubMed ID: 21149632
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat.
Ribeiro S; Garrido P; Fernandes J; Rocha S; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Blood Cells Mol Dis; 2016 Jul; 59():63-70. PubMed ID: 27282570
[TBL] [Abstract][Full Text] [Related]
8. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
9. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
[TBL] [Abstract][Full Text] [Related]
10. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
11. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice.
Díaz V; Gammella E; Recalcati S; Santambrogio P; Naldi AM; Vogel J; Gassmann M; Cairo G
Hepatology; 2013 Dec; 58(6):2122-32. PubMed ID: 23744538
[TBL] [Abstract][Full Text] [Related]
12. Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice.
Sasaki Y; Noguchi-Sasaki M; Matsuo-Tezuka Y; Matsumoto-Omori Y; Kurasawa M; Yorozu K; Shimonaka Y
Int J Hematol; 2014; 99(5):561-9. PubMed ID: 24623262
[TBL] [Abstract][Full Text] [Related]
13. Hypobaric hypoxia regulates iron metabolism in rats.
Li Y; Zhou Y; Zhang D; Wu WY; Kang X; Wu Q; Wang P; Liu X; Gao G; Zhou Y; Wang G; Chang YZ
J Cell Biochem; 2019 Aug; 120(8):14076-14087. PubMed ID: 30968973
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
15. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.
Mirciov CSG; Wilkins SJ; Hung GCC; Helman SL; Anderson GJ; Frazer DM
Haematologica; 2018 Oct; 103(10):1616-1626. PubMed ID: 29903760
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hepcidin expression at high altitude.
Talbot NP; Lakhal S; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Mole DR; Robbins PA
Blood; 2012 Jan; 119(3):857-60. PubMed ID: 22130801
[TBL] [Abstract][Full Text] [Related]
17. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.
Goetze O; Schmitt J; Spliethoff K; Theurl I; Weiss G; Swinkels DW; Tjalsma H; Maggiorini M; Krayenbühl P; Rau M; Fruehauf H; Wojtal KA; Müllhaupt B; Fried M; Gassmann M; Lutz T; Geier A
Hepatology; 2013 Dec; 58(6):2153-62. PubMed ID: 23787477
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure.
Srai SK; Chung B; Marks J; Pourvali K; Solanky N; Rapisarda C; Chaston TB; Hanif R; Unwin RJ; Debnam ES; Sharp PA
Kidney Int; 2010 Oct; 78(7):660-7. PubMed ID: 20631677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
